| Unique ID issued by UMIN | UMIN000056491 |
|---|---|
| Receipt number | R000064556 |
| Scientific Title | A Randomized Controlled Trial of the Effect of Body-Weight-Based HIIT (High Intensity Interval Exercise) on Insulin Resistance in Patients with Type 2 Diabetes Mellitus |
| Date of disclosure of the study information | 2024/12/18 |
| Last modified on | 2024/12/18 14:54:30 |
Effect of HIIT (High Intensity Interval Exercise) on Insulin Resistance in Type 2 Diabetics
Effect of HIIT on Insulin Resistance in Type 2 Diabetics
A Randomized Controlled Trial of the Effect of Body-Weight-Based HIIT (High Intensity Interval Exercise) on Insulin Resistance in Patients with Type 2 Diabetes Mellitus
A Randomized Controlled Trial of the Effect of Body-Weight-Based HIIT on Insulin Resistance in Patients with Type 2 Diabetes Mellitus
| Japan |
Type 2 diabetes
| Endocrinology and Metabolism |
Others
NO
To examine the effect of weight-bearing exercise-based HIIT on insulin resistance in patients with type 2 diabetes mellitus.
Efficacy
Insulin resistance (HOMA-IR)
Fasting insulin, fasting blood glucose, heart rate, blood pressure, subjective exercise intensity
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
3
Educational,Counseling,Training
| Other |
high-intensity interval training
Walking
No special physical activity (control)
| 18 | years-old | <= |
| Not applicable |
Male and Female
Patients diagnosed with type 2 diabetes mellitus, not on insulin therapy, and fasting blood glucose level less than 140 mg/dL, and those who do not have an exercise habit (at least twice a week for at least 30 minutes each time).
a person who is unable to perform HIIT due to a musculoskeletal disorder, a person who is restricted from exercising by his/her physician, a person who has a urine ketone body positive and blood glucose level of 250 mg/dL or higher, a person with pre proliferative retinopathy or higher, a person with over manifest nephropathy (eGFR < 30 mL/min/1.73 m2 or urine albumin level > 300 mg/gCr or urinary protein level of 0.5 g/gCr or higher), ischemic heart disease or cardiopulmonary impairment, uncontrolled hypertension (180/110 mmHg or higher), dyslipidemia (LDL cholesterol level of 140 mg/dL or higher, HDL cholesterol level of less than 40 mg/dL, triglyceride level of less than 40 mg/gCr or higher), and other conditions. HDL cholesterol level less than 40 mg/dL, triglyceride level more than 150 mg/dL), and those with a family history of cardiovascular disease or smoking history.
28
| 1st name | Kumiko |
| Middle name | |
| Last name | Ono |
Kobe University
Graduate School of Health Sciences
654-0142
7-10-2 Tomogaoka, Suma, Kobe, Hyogo, Japan
078-792-2555
onoku@tiger.kobe-u.ac.jp
| 1st name | Kumiko |
| Middle name | |
| Last name | Ono |
Kobe University
Graduate School of Health Sciences
654-0142
7-10-2 Tomogaoka, Suma, Kobe, Hyogo, Japan
078-792-2555
onoku@tiger.kobe-u.ac.jp
Kobe University
None
Self funding
Kobe University Graduate School of Health Sciences, Health Ethics Audit Committee
7-10-2 Tomogaoka, Suma, Kobe, Hyogo, Japan
078-796-4502
syomu2@ams.kobe-u.ac.jp
NO
林医院(兵庫県)
| 2024 | Year | 12 | Month | 18 | Day |
Unpublished
Enrolling by invitation
| 2024 | Year | 02 | Month | 14 | Day |
| 2024 | Year | 02 | Month | 14 | Day |
| 2024 | Year | 02 | Month | 14 | Day |
| 2025 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 12 | Month | 18 | Day |
| 2024 | Year | 12 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064556